Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx-to-OTC switches, focus on Brazil among goals of Warner-Lambert consumer health care.

This article was originally published in The Tan Sheet

Executive Summary

WARNER-LAMBERT OTC SWITCH INTRODUCTION EVERY TWO YEARS beginning in 2001 is one company goal to help boost its consumer health care business. Speaking to securities analysts in New York City April 21, Warner-Lambert President and Chief Operating Officer Lodewijk de Vink identified Rx-to-OTC switches and the expansion of sales in Brazil as two aspects of the company's more aggressive consumer health care growth strategy.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088380

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel